Integra Plus Capsule
NDC Package 52747-712-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Integra Plus (ferrous fumarate and polysacchride iron vitamin mineral complex supplement) capsules is cONTRAINDICATIONS: Integra PlusTM is contraindicated in patients with a known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. This formulation utilizes a capsule delivery system. Marketed by U.s. Pharmaceutical Corporation, this product is identified by NDC 52747-712.

Identification & Billing

NDC Package Code
52747-712-60
Package Description
90 CAPSULE in 1 BOTTLE, PLASTIC
Product Code
52747-712
11-Digit Billing Format
52747071260
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
90 EA

Clinical Specifications

Proprietary Name
Integra Plus
Non-Proprietary Name
Ferrous Fumarate And Polysacchride Iron Vitamin Mineral Complex Supplement
Substance Name
Ascorbic Acid; Biotin; Calcium Pantothenate; Ferrous Asparto Glycinate; Ferrous Fumarate; Folic Acid; Niacin; Pyridoxine Hydrochloride; Riboflavin; Thiamine Mononitrate
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
CONTRAINDICATIONS: Integra PlusTM is contraindicated in patients with a known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. Pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.

Regulatory & Marketing

Labeler Name
U.s. Pharmaceutical Corporation
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
04-27-2009
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (52747-712). Click a package code to view its specific billing and regulatory data.

52747-712-10
40 BLISTER PACK in 1 BOX / 4 CAPSULE in 1 BLISTER PACK (52747-712-04)
52747-712-30
30 CAPSULE in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 52747-712-60 identifies a specific commercial package of 90 capsule in 1 bottle, plastic of Integra Plus, a human prescription drug labeled by U.s. Pharmaceutical Corporation. This capsule is formulated for oral use and contains ascorbic acid; biotin; calcium pantothenate; ferrous asparto glycinate; ferrous fumarate; folic acid; niacin; pyridoxine hydrochloride; riboflavin; thiamine mononitrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by U.s. Pharmaceutical Corporation on April 27, 2009. The current certification is valid through December 31, 2026.

How is this U.s. Pharmaceutical Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 52747071260. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
52747-712-60
11-Digit CMS (5-4-2)
52747-0712-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.